Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
307.83
263.07
272.21
215.82
364.62
314.78
250.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
307.83
263.07
272.21
215.82
364.62
314.78
250.96
Raw Material Cost
119.29
82.01
117.10
103.45
185.87
86.86
81.49
Purchase of Finished goods
3.92
0.00
1.20
5.30
17.28
5.49
4.76
(Increase) / Decrease In Stocks
12.95
2.90
-5.25
38.65
-56.64
10.89
-21.29
Employee Cost
93.43
80.94
73.49
63.91
90.14
72.62
67.58
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
97.21
104.21
99.54
88.16
123.50
78.37
101.03
Total Expenditure (Excl Depreciation)
326.80
270.06
286.08
299.47
360.15
254.23
233.57
Operating Profit (PBDIT) excl Other Income
-18.97
-6.99
-13.87
-83.65
4.47
60.55
17.39
Other Income
12.07
8.45
9.31
22.66
5.26
3.19
8.48
Operating Profit (PBDIT)
-6.90
1.46
-4.56
-60.99
9.73
63.74
25.87
Interest
3.00
1.85
1.91
2.43
98.05
92.74
82.28
Exceptional Items
14.02
5.51
30.51
55.51
0.00
0.00
-15.40
Gross Profit (PBDT)
4.12
5.12
24.04
-7.91
-88.32
-29.00
-71.81
Depreciation
16.73
17.41
18.79
19.94
21.96
22.71
22.44
Profit Before Tax
-12.61
-12.29
5.25
-27.85
-110.28
-51.71
-94.25
Tax
-2.56
-1.12
2.56
12.59
0.00
0.43
5.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-10.05
-11.17
2.69
-40.44
-110.28
-52.14
-99.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
-1.45
-3.94
Net Profit
-10.05
-11.17
2.69
-40.44
-110.28
-53.59
-103.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.13
0.10
Minority Interest
0.18
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-9.87
-11.17
2.69
-40.44
-110.28
-53.46
-103.27
Equity Capital
6.13
6.13
6.13
6.13
6.13
6.13
6.13
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
-344.97
0.00
0.00
Earnings per share (EPS)
-1.61
-1.82
0.44
-6.6
-17.99
-8.72
-15.46
Diluted Earnings per share
-1.62
-1.8
0.44
-6.6
-18.02
-24.19
-16.86
Operating Profit Margin (Excl OI)
-6.16%
-2.66%
-5.1%
-38.76%
1.23%
19.24%
6.93%
Gross Profit Margin
1.34%
1.95%
8.83%
-3.67%
-24.22%
-9.21%
-28.61%
PAT Margin
-3.26%
-4.25%
0.99%
-18.74%
-30.25%
-16.52%
-39.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 17.01% vs -3.36% in Sep 2024
Consolidate Net Profit
Growth in half year ended Sep 2025 is 11.64% vs -515.24% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is -171.39% vs 49.60% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 62.16% vs -3.14% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of Panacea Biotec With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
307.83
836.81
-528.98
-63.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
307.83
836.81
-528.98
-63.21%
Raw Material Cost
119.29
458.34
-339.05
-73.97%
Purchase of Finished goods
3.92
49.02
-45.10
-92.00%
(Increase) / Decrease In Stocks
12.95
19.19
-6.24
-32.52%
Employee Cost
93.43
111.89
-18.46
-16.50%
Power Cost
0.00
21.73
-21.73
-100.00%
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
56.04
-56.04
-100.00%
Other Expenses
97.21
65.74
31.47
47.87%
Total Expenditure (Excl Depreciation)
326.80
781.95
-455.15
-58.21%
Operating Profit (PBDIT) excl Other Income
-18.97
54.86
-73.83
-134.58%
Other Income
12.07
9.04
3.03
33.52%
Operating Profit (PBDIT)
-6.90
63.90
-70.80
-110.80%
Interest
3.00
8.22
-5.22
-63.50%
Exceptional Items
14.02
25.83
-11.81
-45.72%
Gross Profit (PBDT)
4.12
81.51
-77.39
-94.95%
Depreciation
16.73
20.31
-3.58
-17.63%
Profit Before Tax
-12.61
61.21
-73.82
-120.60%
Tax
-2.56
8.76
-11.32
-129.22%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-10.05
52.45
-62.50
-119.16%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-10.05
52.45
-62.50
-119.16%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.18
-0.83
1.01
121.69%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-9.87
51.62
-61.49
-119.12%
Equity Capital
6.13
109.58
-103.45
-94.41%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
-1.61
0.94
-2.55
-271.28%
Diluted Earnings per share
-1.62
0.95
-2.57
-270.53%
Operating Profit Margin (Excl OI)
-6.16%
6.56%
0.00
-12.72%
Gross Profit Margin
1.34%
9.74%
0.00
-8.40%
PAT Margin
-3.26%
6.27%
0.00
-9.53%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 307.83 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 17.01% vs -3.36% in Sep 2024
Half Yearly - Consolidate Net Profit
Consolidate Net Profit -9.87 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 11.64% vs -515.24% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -18.97 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -171.39% vs 49.60% in Sep 2024
Half Yearly - Interest
Interest 3.00 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 62.16% vs -3.14% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -6.16%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024






